Scilex Holding Co Announces It Has Received the Drug Distributor Accreditation From The National Association Of Boards Of Pharmacy
Scilex Holding Co Announces It Has Received the Drug Distributor Accreditation From The National Association Of Boards Of Pharmacy
Scilex控股公司宣佈已獲得國家藥品配送商認證委員會的藥品配送商資質
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy (NABP). Scilex has satisfied all the drug distributor criteria set in place by the NABP.
Scilex控股公司（納斯達克股票代碼：SCLX，"Scilex"或"公司"），一家創新的營業收入公司，專注於收購、開發和商業化非阿片類疼痛管理產品，用於急性和慢性疼痛治療。今天宣佈獲得了全國藥品配送商藥品配送商認證（NABP）認證。 Scilex已滿足了NABP設定的所有藥品配送商標準。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。